Seeking Alpha

Seeking Alpha Portfolio App for iPad

LATEST ARTICLES

ARTICLES | NEWS | TRANSCRIPTS

Potential DelMar Investors Await First 10Q Filings From The Sidelines
Chemistfrog • DMPI.OB • Wed, May 15, 04:09 ET
Anacor Pharmaceuticals: Should Retail Follow Institutions On This Biotech?
EnhydrisPECorp • ANAC • Tue, May 14, 10:58 ET
Herbalife: What Have We Learned?
William Keep • HLF • Thu, May 9, 06:10 ET
How To Maximize Shareholder Value In Natural Alternatives International
Microcap Bargin Hunter • NAII • Wed, May 8, 10:25 ET
Perrigo - A Healthy Bet For Your Portfolio
Richard Tarjeft • PRGO • Tue, May 7, 07:23 ET
DelMar Pharmaceuticals: A Small Cap Worth Considering
Dutch Trader • DMPI.OB • Mon, May 6, 15:33 ET
Regulus Therapeutics: Strong Balance Sheet As It Moves Into Clinical Development
Bay Area Biotech • RGLS • Mon, May 6, 14:40 ET
LifeVantage: A Cure For Marketing, And Maybe One For Aging
CBOE Trader • LFVN • Mon, May 6, 10:39 ET
Cipher Pharma Continues To Deliver
Jason Napodano • CPHMF.PK • Mon, May 6, 05:10 ET
Herbalife's 'Build It Better' Program: 1 Thing That Still Needs To Change
Fusion Research • HLF • Fri, May 3, 18:05 ET
Why Robert Chapman Is A Better Leading Indicator Of The True Value Of Herbalife Than Bill Ackman
Patent News • NUS, HLF • Fri, May 3, 08:29 ET
Post-IPO Strength Seen In Stemline Therapeutics
Brian L. Wilson • STML • Thu, May 2, 17:43 ET
Weak Quarter At Auxilium Overshadows Execution On Long-Term Strategy
PropThink • ENDP, AUXL • Wed, May 1, 12:43 ET
Herbalife's Ackman Charge And Earnings Review
Profit Fan • HLF • Tue, Apr 30, 06:34 ET
Emerging Health Food Company With Upside Potential
Emerging Growth • WFM, CYAN • Thu, Apr 25, 09:00 ET
Big Biopharma Eyes Long Acting Diabetes Drugs
Takeover Analyst • BMY, ANTB.OB • Thu, Apr 25, 07:49 ET
DelMar IPO Obscurity Could Offer Investors Favorable Entry
Chemistfrog • DMPI.OB • Wed, Apr 24, 05:32 ET
ARM Holdings' Biotech Twin: FluoroPharma
Logical Assessment • FPMI.OB • Wed, Apr 17, 11:08 ET
My Thoughts On Taro
Mitchell Sacks • MYL, ACT, PRGO • Sun, Apr 14, 00:45 ET
Roche's Oncology Unit Drives Strong Results And Tamiflu Strength Surprises
Trefis • RHHBY.OB • Fri, Apr 12, 11:57 ET
DelMar Pharmaceuticals: New, Promising Data For Glioblastoma Drug
Brian L. Wilson • DMPI.OB • Thu, Apr 11, 10:54 ET
Herbalife KPMG Affair Compelling Opportunity For Shareholders
Tufenk • HLF • Thu, Apr 11, 04:56 ET
5 New Questions For Herbalife Investors
Matt Stewart • HLF • Wed, Apr 10, 09:09 ET
Roche Earnings Preview: What We Are Watching
Trefis • RHHBY.OB • Tue, Apr 9, 15:06 ET
William Demant Moves Into Fast Growing Cochlear Implant Sector
EP Vantage • WILLF.PK • Wed, Apr 3, 14:38 ET
Roche Mulls Bid For Genetic Sequencing Company Life Technologies
Trefis • LIFE, RHHBY.OB • Mon, Apr 1, 13:17 ET
Auxilium Has A Proven CEO Who's On A Path To Shareholder Value
PropThink • AUXL • Mon, Apr 1, 09:31 ET
Is Anacor's Latest Drug Development A Potential Blockbuster?
C.R. Jackson • ABT, AMGN, JNJ • Thu, Mar 28, 11:27 ET
Anacor Rallies On AN2728 Progress And Market Attention
Brian L. Wilson • ANAC • Tue, Mar 26, 19:29 ET
What Bill Ackman Doesn't Want You To Know About The FHTM Case
Fusion Research • HLF • Mon, Mar 25, 21:34 ET
Is Herbalife A Pyramid Scheme? ¿Quien Sabe?
Robert FitzPatrick • HLF • Thu, Mar 21, 10:13 ET
Herbalife Is Not Going To Zero
Steve Alosio • HLF • Wed, Mar 20, 11:37 ET
Herbalife: Beware The White Knight
Kyle Spencer • HLF • Tue, Mar 19, 13:47 ET
These 3 Well-Known Hedge Funds Are Also In HerbaLife
Alpha Stratus • HLF • Tue, Mar 19, 11:36 ET
Why Implant Sciences Reminds Me Of Celgene's Oft-Forgotten Humble Beginnings
Mars Report • CELG, IMSC.PK • Mon, Mar 18, 11:39 ET
Herbalife: 5 Common Sense Arguments
Matt Stewart • HLF • Mon, Mar 18, 08:06 ET
Roche Holdings: New Drugs Drive Oncology Unit's Growth
Trefis • RHHBY.OB • Fri, Mar 15, 18:17 ET
Expensive And Hard To Own, Natura Cosmeticos Is Still A Great Brazil Play
Stephen Simpson • PG, AVP, UL • Fri, Mar 15, 15:47 ET
The World Is Fat: The Law Of Supply And Demand And The Western Diet
Luigi Gratton • HLF • Fri, Mar 15, 09:00 ET
Pharma Heavy Hitters Bet On Retrophin To Battle Orphan Diseases As FDA Speeds Up Commercialization
Sharon di Stefano • RTRX.OB • Thu, Mar 14, 06:08 ET
One Of Herbalife's Greatest Risks
Douglas Brooks • HLF • Wed, Mar 13, 09:51 ET
Shattering The Personal Consumption Myth 2.0
Matt Stewart • HLF • Wed, Mar 13, 08:07 ET
Tonix Readies For Pivotal Fibromyalgia Program
Jason Napodano • TNXP.OB • Wed, Mar 13, 05:35 ET
Herbalife: Icahn Literally Leaps On Board
Craig Van Pelt • HLF • Thu, Mar 7, 16:55 ET
Aspen Pharmacare Offers Very Expensive Developing World Growth
Stephen Simpson • SNY, GSK, NVS • Wed, Mar 6, 15:20 ET
Tonix Pharmaceuticals: Revolutionizing Fibromyalgia Treatment
Capital Traders Group • TNXP.OB • Wed, Mar 6, 10:57 ET
Herbalife's Tragic Flaw: Understanding Inventory Loading
Matt Stewart • NUS, HLF • Wed, Mar 6, 09:18 ET
Herbalife: Putting Bill Ackman's Arguments In Perspective
Fusion Research • HLF • Mon, Mar 4, 15:27 ET
Publicly Available Lessons Regarding Pyramid Schemes: What Should We Think About Herbalife?
William Keep • HLF • Mon, Mar 4, 13:15 ET
Herbalife Is An Endless Chain
Matt Stewart • HLF • Fri, Mar 1, 16:01 ET

First Page
Previous Page
1 - 50 of 546
Next Page
Last Page